Lymphoscintigraphy in gynecologic malignancies.
Lymphoscintigraphy is an easily performed noninvasive procedure that offers the potential to detect small numbers of ascitic tumor cells and early diaphragmatic tumor involvement. Moreover, it can be used to delineate and define abnormalities in lymph nodes that are not routinely visualized by bipedal contrast lymphangiography, ultrasound or computed tomography. Lymphoscintigraphy is recommended as an important investigative and adjunctive procedure in diagnosing gynecologic malignancies; there does not appear to be sufficient sensitivity and specificity to justify its routine clinical use.
D000818:Animals; D001201:Ascites / Q000000981:diagnostic imaging / Q000209:etiology; D001940:Breast / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging* / Q000502:physiology; D008482:Mediastinum / Q000000981:diagnostic imaging; D051379:Mice; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D013455:Sulfur / Q000008:administration & dosage; D013667:Technetium / Q000008:administration & dosage; D013671:Technetium Tc 99m Sulfur Colloid; D002583:Uterine Cervical Neoplasms / Q000000981:diagnostic imaging*; D014594:Uterine Neoplasms / Q000000981:diagnostic imaging*
D013671:Technetium Tc 99m Sulfur Colloid; D013455:Sulfur; D013667:Technetium